Preclinical and clinical aspects of biomodulation of 5-fluorouracil
Authors:
- Liam GroganLGLiam Grogan
- Carmen J. AllegraCACarmen J. Allegra
- 31 January 1994
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 20 (1) , 11-49
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinomaEuropean Journal of Cancer, 1992
- Decreased Catabolism of Fluorouracil in Peripheral Blood Mononuclear Cells During Combination Therapy With Fluorouracil, Leucovorin, and Interferon -2aJNCI: Journal of the National Cancer Institute, 1992
- Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cellsBiochemical and Biophysical Research Communications, 1992
- Cisplatinum in Combination with 5-Fluorouracil and Citrovorum Factor in the Treatment of Advanced Colorectal CarcinomaCancer Investigation, 1992
- Interferon effects upon fluorouracil metabolism by HL-60 cellsBiochemical and Biophysical Research Communications, 1989
- Reversal of 5-Fluorouracil-Induced Myelosuppression by Prolonged Administration of High-Dose UridineJNCI: Journal of the National Cancer Institute, 1989
- The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and α-tocopherolEuropean Journal of Cancer and Clinical Oncology, 1982
- Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines.Journal of Clinical Investigation, 1980
- Selective enhancement of 5-fluorouridine uptake and action in rat hepatomas in vivo following pretreatment with d-galactosamine and 6-azauridine or N-(phosphonacetyl)-l-aspartate1980
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979